journal article·2023-10-24Open access

Amphiphilic Particle-Stabilized Nanoliter Droplet Reactors with a Multimodal Portable Reader for Distributive Biomarker Quantification

Vishwesh Shah, Xilin Yang, Alyssa Arnheim, Shreya Udani, Derek Tseng, Yi Luo, Mengxing Ouyang, Ghulam Destgeer, Omai B. Garner, Hatice C. Koydemir, Aydogan Ozcan, Dino Di Carlo

ACS Nano· Volume 17· Issue 20

Abstract

Compartmentalization, leveraging microfluidics, enables highly sensitive assays, but the requirement for significant infrastructure for their design, build, and operation limits access. Multimaterial particle-based technologies thermodynamically stabilize monodisperse droplets as individual reaction compartments with simple liquid handling steps, precluding the need for expensive microfluidic equipment. Here, we further improve the accessibility of this lab on a particle technology to resource-limited settings by combining this assay system with a portable multimodal reader, thus enabling nanoliter droplet assays in an accessible platform. We show the utility of this platform in measuring N-terminal propeptide B-type natriuretic peptide (NT-proBNP), a heart failure biomarker, in complex medium and patient samples. We report a limit of detection of ∼0.05 ng/mL and a linear response between 0.2 and 2 ng/mL in spiked plasma samples. We also show that, owing to the plurality of measurements per sample, "swarm" sensing acquires better statistical quantitation with a portable reader. Monte Carlo simulations show the increasing capability of this platform to differentiate between negative and positive samples, i.e., below or above the clinical cutoff for acute heart failure (∼0.1 ng/mL), as a function of the number of particles measured. Our platform measurements correlate with gold standard ELISA measurement in cardiac patient samples, and achieve lower variation in measurement across samples compared to the standard well plate-based ELISA. Thus, we show the capabilities of a cost-effective droplet-reader system in accurately measuring biomarkers in nanoliter droplets for diseases that disproportionately affect underserved communities in resource-limited settings.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Innovative Microfluidic and Catalytic Techniques Innovation · Microfluidic and Bio-sensing Technologies · Microfluidic and Capillary Electrophoresis Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Bioengineering, University of California - Los Angeles, Los Angeles, California 90095, United States

Department of Electrical and Computer Engineering, University of California - Los Angeles, Los Angeles, California 90095, United States

Department of Electrical Engineering, Technical University of Munich, Munich 80333, Germany

Department of Pathology and Laboratory Medicine, University of California - Los Angeles, Los Angeles, California 90095, United States

Center for Remote Health Technologies and Systems, Texas A&M Engineering Experiment Station, College Station, Texas 77843, United States

Department of Biomedical Engineering, Texas A&M University, College Station, Texas 77843, United States

California Nanosystems Institute (CNSI), University of California - Los Angeles, Los Angeles, California 90095, United States

Funding

Engineering Research Centers

References (28)

Show source-provided references
1. 10.1177/247263031770568010.1177/2472630317705680 ↗
2. 10.1177/247263031770568110.1177/2472630317705681 ↗
3. 10.1038/nbt.164110.1038/nbt.1641 ↗
4. 10.1073/pnas.181411011610.1073/pnas.1814110116 ↗
5. 10.1038/nbt107210.1038/nbt1072 ↗
6. 10.1038/ncomms1039210.1038/ncomms10392 ↗
7. 10.1126/sciadv.abb902310.1126/sciadv.abb9023 ↗
8. 10.1039/D0LC00698J10.1039/D0LC00698J ↗
9. 10.1007/s11883-016-0559-410.1007/s11883-016-0559-4 ↗
10. 10.1161/CIR.000000000000065910.1161/CIR.0000000000000659 ↗
11. 10.1161/CIR.000000000000015210.1161/CIR.0000000000000152 ↗
12. 10.1161/CIR.000000000000095010.1161/CIR.0000000000000950 ↗
13. 10.1001/archinte.168.19.213810.1001/archinte.168.19.2138 ↗
14. 10.3399/BJGPO.2021.000610.3399/BJGPO.2021.0006 ↗
15. 10.1016/j.jacc.2017.04.02510.1016/j.jacc.2017.04.025 ↗
16. 10.1016/j.jacc.2013.01.05210.1016/j.jacc.2013.01.052 ↗
17. 10.1021/acs.analchem.0c0418410.1021/acs.analchem.0c04184 ↗
18. 10.1039/D2LC00421F10.1039/D2LC00421F ↗
19. 10.1016/j.bios.2019.02.05610.1016/j.bios.2019.02.056 ↗
20. 10.1093/eurheartj/ehw12810.1093/eurheartj/ehw128 ↗
21. 10.1161/CIR.000000000000049010.1161/CIR.0000000000000490 ↗
22. 10.1016/j.cjca.2017.08.02210.1016/j.cjca.2017.08.022 ↗
23. 10.1109/83.50676110.1109/83.506761 ↗
24. 10.1109/ICIP.1999.81709110.1109/ICIP.1999.817091 ↗
25. 10.1109/83.50676110.1109/83.506761 ↗
26. 10.1016/B978-0-12-336156-1.50061-610.1016/B978-0-12-336156-1.50061-6 ↗
27. 10.1109/ICCV.1998.71081510.1109/ICCV.1998.710815 ↗
28. 10.1109/TPAMI.1986.476785110.1109/TPAMI.1986.4767851 ↗